Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

Activities

Vall d'Hebron Talks by VHIR 'Long-term impact of stroke on systemic immunity'

Speaker: Dr. Alba Simats Oriol, MSCA postdoctoral researcher at Institute of Biomedical Research at the Spanish Research Council (CSIC), Abstract:  Stroke leads to a significant medical burden, not just from brain injury itself but also due to subsequent secondary complications and

Activities

Vall d'Hebron Talks 'Humanització de la Unitat de Cures Intensives Pediàtriques a través de les famílies'

Ponent: Patricia Rubio Garrido, infermera suport de cures. Gestió del coneixement i avaluació de l'Hospital Universitari Vall d'Hebron. La humanització de les cures en la Unitat de Cures Intensives Pediàtriques (UCIP), fa referència a l'aplicació d'un enfocament d'actuació sanitària bas

News

Més de 500 persones obren les celebracions del 30 aniversari del Vall d'Hebron Institut de Recerca participant en la 1a Cursa Vall d’Hebron

El primer dels esdeveniments que s’han organitzat per celebrar els 30 anys del VHIR i ha complert amb èxit el seu propòsit de ser una trobada popular entre professionals de Vall d’Hebron i veïns i veïnes del barri en benefici de la recerca

News

Genetic basis of ADHD and autism spectrum disorder impacts on children's school performance

These results reinforce the need for more individualized attention to address educational needs from an early stage.

Activities

ESID Summerschool Open Session on Inborn Errors of Immunity

The ESID Summerschool Open Session is a highly informative event that aims to bridge the gap between local healthcare professionals and the field of Primary Immunodeficiencies. This session features four engaging talks and two intriguing clinical cases, all pre

Activities

2a edició de la Jornada 'Sumem Dades, Multipliquem Coneixement'

Darreres entrades presencials: https://www.eventbrite.es/e/2a-jornada-sumem-dades-multipliquem-coneixement-tickets-894352742127

News

BSC launches clinical validation of radiation-free breast cancer diagnostic technique at Vall d'Hebron

This new technology will be completely harmless for patients, as it does not use radiation, and will offer superior image quality and better monitoring of tumours, among other benefits.

News

Dr. Gabriela Guillén of Vall d'Hebron receives the award for best presentation at the LXI Congress of the SECP

"Generation of a bank of surgical orthotopic PDX (patient-derived xenografts) models within the framework of a personalized medicine program in pediatric cancer" was the awarded work, of the Childhood Cancer and Hematological Diseases Group of VHIR.

News

For the second year in a row, a research study from the Vall d'Hebron Urology Service has been recognised by the UB-HUB Chair of Robotic Surgery ABEX

The work led by Dr. Regis demonstrates that performing robotic reconstruction after radical prostatectomy is associated with better urinary control.

Activities

Vall d'Hebron Talks 'ITS, què és important saber'

Ponent : Dra. Maider Arando, especialista en medicina interna / infeccioses. Facultativa especialista a la Unitat d'ITS Vall d'Hebron-Drassanes des de l'any 2008. Doctora per la universitat de la UAB el 2019, la tesi va ser sobre sífilis. Resum: explicació sobre les ITS exsudatives (gon

Activities

Defensa de Tesi 'Noves dianes terapèutiques en sepsi'

Doctorand: Luis Silvestre Chiscano Camón, grup de Recerca de Shock, Disfunció Orgànica i Ressucitació. Vall d'Hebrton Institut de Recerca (VHIR) Directors: Dr. Ricard Ferrer Roca i Dr. Juan Carlos Ruiz Rodríguez Tutor: Dr. Ricard Ferrer Roca

News

VHIR exceeds 700 active clinical trials to achieve new therapies for patients

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

News

Biomarkers gain prominence in paediatric cancer clinical trials

A study, co-led by Vall d’Hebron, has analysed the evolution of clinical trials with children and adolescents with cancer over the last 15 years, with the aim of optimising efficacy and defining lines for further progress.

News

Vall d'Hebron boosts the search for new drugs for head and neck cancer

The Biomedical Research in Cancer Stem Cells group at VHIR has identified a new therapeutic target and is working to find new therapies for this type of tumor.

Activities

Vall d'Hebron Talks 'Angioedema Hereditari: Què és i com reconèixer-ho?'

Ponent: Dra. Mar Guilarte Clavero, adjunta del Servei d'Al·lergologia. Coordinadora Centre de Referència CSUR d'Angioedema Hereditari. Hospital Universitari Vall d'Hebron. L'Angioedema Hereditari (AEH) és una malaltia minoritària, que sovint és desconeguda per molts professionals sanita

Activities

Symposium 'Career Day'

Program: 09-00 – 09.10 Welcome to Career Day, Dr. Anna Santamaria Margalef, Internal Strategy Director, VHIR

Activities

Jornada del Dia Mundial del Lupus

Programa 16.00h Presentació Dia Mundial del Lupus Sra. Maria Royo, investigadora i Coordinadora d'assajos clínics de la unitat Lupus-Reumatologia de la Vall d'Hebron Institut de Recerca. 16.15h Noves teràpies al Lupus Eritematós Sistèmic Dra. Josefina Cortés-Hern

News

Identified one of the mechanisms involved in the progression of Dent's disease to renal fibrosis

Researchers at the VHIR have carried out a study showing that the ClC-5 protein regulates collagen levels through the β-catenin pathway and lysosomal degradation.

Activities

Vall d'Hebron Talks by VHIR 'Towards the utilization of cannabinoids as anticancer agents and other stories inspired by cannabis'

Speaker: Dr. Guillermo Velasco Díez, deparment of Biochemistry and Molecular Biology, School of Biology, Complutense University. Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), 28040-Madrid. Spain A large body of evidence shows that cannabinoids, in additi

News

1st Vall d'Hebron Ventures Summit

El VHIR organitza la primera trobada entre emprenedors i l’ecosistema inversor.